Shockwave Medical, Inc. is a medical device company that focuses on developing and commercializing products intended to transform the treatment of calcified cardiovascular disease. The company is known for its innovative use of sonic pressure waves to address the challenges of calcified plaque in patients with cardiovascular disease.

Shockwave Medical is committed to improving patient outcomes through its pioneering technology, which aims to provide a safer and more effective treatment option compared to traditional methods. The company's products are designed to enhance the quality of life for patients while reducing the overall cost of care.

Regarding sustainability, there is limited publicly available information on Shockwave Medical's environmental and social governance practices. The company does not prominently feature sustainability reports or carbon footprint data on its website or other public platforms. As a medical device company, its primary focus appears to be on innovation and patient care rather than environmental sustainability initiatives.